Physician profile
Neal Dollin
NPI 1053705384
$13,287.35
in general payments reported to CMS, 2019-2025
26 companies · $2,870 in 2025
The $2,870 reported for 2025 was more than what 77% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,792 · 2022: $3,629 · 2023: $1,772 · 2024: $3,225 · 2025: $2,870.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,568 · Travel and Lodging: $1,997 · Education: $301.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,567.94 |
| Travel and Lodging | $1,996.95 |
| Education | $301.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $2,441.92 | 2021-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Excluder Aaa Endoprosthesis, Gore Viabahn Endoprosthesis With Heparin |
| Silk Road Medical, INC. | $2,431.32 | 2021-2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Medtronic, INC. | $2,073.52 | 2021-2025 | Endurant Iis |
| Steris Corporation | $2,028.05 | 2024 | |
| Shockwave Medical, INC | $925.91 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Imperative Care, INC | $581.13 | 2024-2025 | Symphony Catheter, Prodigy Catheter |
| Endologix LLC | $392.16 | 2021-2024 | Endocross Device, Torus Stent Graft System |
| Stryker Corporation | $339.63 | 2025 | Artix Mt, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cvrx, INC. | $334.50 | 2024-2025 | Barostim Neo System |
| Kerecis Limited | $282.77 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Abiomed | $255.03 | 2024-2025 | Impella |
| Edwards Lifesciences Corporation | $198.99 | 2025 | Sapien 3 Ultra Resilia |
| Abbott Laboratories | $159.07 | 2025 | Xact |
| Smith+Nephew, INC. | $130.14 | 2024-2025 | Collagenase Santyl, Stravix, Grafix |
| Boston Scientific Corporation | $121.11 | 2025 | Enroute Transcarotid Stent |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $115.63 | 2023 | Indigo System |
| Lemaitre Vascular, INC. | $103.94 | 2023-2025 | Artegraft Vascular Graft, Pruitt F3 Carotid Shunt, Restoreflow |
| Inari Medical, INC. | $90.13 | 2024-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Shape Memory Medical INC. | $55.48 | 2022 | |
| Integra Lifesciences Corporation | $51.86 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Acera Surgical, INC. | $46.15 | 2022-2024 | Restrata Wound Matrix |
| Tactile Systems Technology INC | $46.15 | 2024-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Sanara Medtech INC. | $33.61 | 2023-2024 | Biasurge, Celleraterx |
| Solventum Corporation | $20.13 | 2024 | V.A.C.Instill, Prevena |
| Arjo INC. | $16.01 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.01 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neal Dollin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.